In The News Posted March 4, 2019 Share Posted March 4, 2019 SAN DIEGO, March 4, 2019 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will participate in two upcoming investor conferences. The 39th Annual Cowen Healthcare Conference on Monday, March 11 at... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.